Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 78

1.

Myotonic dystrophies type 1 and 2: anesthetic care.

Veyckemans F, Scholtes JL.

Paediatr Anaesth. 2013 Sep;23(9):794-803. doi: 10.1111/pan.12120. Epub 2013 Feb 5. Review.

PMID:
23384336
2.

The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes.

Sansone VA, Brigonzi E, Schoser B, Villani S, Gaeta M, De Ambroggi G, Bandera F, De Ambroggi L, Meola G.

Int J Cardiol. 2013 Sep 30;168(2):1147-53. doi: 10.1016/j.ijcard.2012.11.076. Epub 2012 Dec 23.

PMID:
23266299
3.

Myotonic dystrophy: from bench to bedside.

Johnson NE, Heatwole CR.

Semin Neurol. 2012 Jul;32(3):246-54. doi: 10.1055/s-0032-1329202. Epub 2012 Nov 1. Review.

PMID:
23117949
4.

Sleep disturbances in myotonic dystrophy type 2.

Shepard P, Lam EM, St Louis EK, Dominik J.

Eur Neurol. 2012;68(6):377-80. doi: 10.1159/000342895. Epub 2012 Oct 25.

5.

The myotonic dystrophies: molecular, clinical, and therapeutic challenges.

Udd B, Krahe R.

Lancet Neurol. 2012 Oct;11(10):891-905. doi: 10.1016/S1474-4422(12)70204-1. Review.

PMID:
22995693
6.

Sleep disordered breathing and other sleep dysfunction in myotonic dystrophy type 2.

Bhat S, Sander HW, Grewal RP, Chokroverty S.

Sleep Med. 2012 Oct;13(9):1207-8. doi: 10.1016/j.sleep.2012.07.001. Epub 2012 Sep 5. No abstract available.

PMID:
22959494
7.

Delayed contrast enhancement on cardiac MRI unmasks subclinical cardiomyopathy in a case of myotonic dystrophy type 2.

Spengos K, Gialafos E, Vassilopoulou S, Toulas P, Manta P.

Hellenic J Cardiol. 2012 Jul-Aug;53(4):324-6.

8.

Nuclear ribonucleoprotein-containing foci increase in size in non-dividing cells from patients with myotonic dystrophy type 2.

Giagnacovo M, Malatesta M, Cardani R, Meola G, Pellicciari C.

Histochem Cell Biol. 2012 Oct;138(4):699-707. doi: 10.1007/s00418-012-0984-6. Epub 2012 Jun 17.

PMID:
22706481
9.

REM behavior disorder in myotonic dystrophy type 2.

Chokroverty S, Bhat S, Rosen D, Farheen A.

Neurology. 2012 Jun 12;78(24):2004. doi: 10.1212/WNL.0b013e318259e28c. No abstract available.

PMID:
22689737
10.

Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.

Kamsteeg EJ, Kress W, Catalli C, Hertz JM, Witsch-Baumgartner M, Buckley MF, van Engelen BG, Schwartz M, Scheffer H.

Eur J Hum Genet. 2012 Dec;20(12):1203-8. doi: 10.1038/ejhg.2012.108. Epub 2012 May 30.

11.

Clinical, electrophysiologic and pathologic findings in 10 patients with myotonic dystrophy 2.

Dabby R, Sadeh M, Herman O, Leibou L, Kremer E, Mordechai S, Watemberg N, Frand J.

Isr Med Assoc J. 2011 Dec;13(12):745-7.

12.

Cerebral and muscle MRI abnormalities in myotonic dystrophy.

Franc DT, Muetzel RL, Robinson PR, Rodriguez CP, Dalton JC, Naughton CE, Mueller BA, Wozniak JR, Lim KO, Day JW.

Neuromuscul Disord. 2012 Jun;22(6):483-91. doi: 10.1016/j.nmd.2012.01.003. Epub 2012 Jan 30.

13.

Increased cancer risks in myotonic dystrophy.

Win AK, Perattur PG, Pulido JS, Pulido CM, Lindor NM.

Mayo Clin Proc. 2012 Feb;87(2):130-5. doi: 10.1016/j.mayocp.2011.09.005. Epub 2012 Jan 10.

14.

Pain in patients with myotonic dystrophy type 2: a postal survey in Finland.

Suokas KI, Haanpää M, Kautiainen H, Udd B, Hietaharju AJ.

Muscle Nerve. 2012 Jan;45(1):70-4. doi: 10.1002/mus.22249.

PMID:
22190310
15.

Cancer risk among patients with myotonic muscular dystrophy.

Gadalla SM, Lund M, Pfeiffer RM, Gørtz S, Mueller CM, Moxley RT 3rd, Kristinsson SY, Björkholm M, Shebl FM, Hilbert JE, Landgren O, Wohlfahrt J, Melbye M, Greene MH.

JAMA. 2011 Dec 14;306(22):2480-6. doi: 10.1001/jama.2011.1796.

16.

Myotonic dystrophies and the heart.

Chaudhry SP, Frishman WH.

Cardiol Rev. 2012 Jan-Feb;20(1):1-3. doi: 10.1097/CRD.0b013e31821950f9. Review.

PMID:
22143278
17.

Myotonic dystrophy type 2 (DM2) and related disorders report of the 180th ENMC workshop including guidelines on diagnostics and management 3-5 December 2010, Naarden, The Netherlands.

Udd B, Meola G, Krahe R, Wansink DG, Bassez G, Kress W, Schoser B, Moxley R.

Neuromuscul Disord. 2011 Jun;21(6):443-50. doi: 10.1016/j.nmd.2011.03.013. Epub 2011 May 4. No abstract available.

PMID:
21543227
18.

High disease impact of myotonic dystrophy type 2 on physical and mental functioning.

Tieleman AA, Jenks KM, Kalkman JS, Borm G, van Engelen BG.

J Neurol. 2011 Oct;258(10):1820-6. doi: 10.1007/s00415-011-6027-8. Epub 2011 Apr 3.

19.

Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.

Suominen T, Bachinski LL, Auvinen S, Hackman P, Baggerly KA, Angelini C, Peltonen L, Krahe R, Udd B.

Eur J Hum Genet. 2011 Jul;19(7):776-82. doi: 10.1038/ejhg.2011.23. Epub 2011 Mar 2.

20.

Side effects of anesthesia in DM2 as compared to DM1: a comparative retrospective study.

Kirzinger L, Schmidt A, Kornblum C, Schneider-Gold C, Kress W, Schoser B.

Eur J Neurol. 2010 Jun 1;17(6):842-5. doi: 10.1111/j.1468-1331.2009.02942.x. Epub 2010 Jan 20.

PMID:
20100232

Supplemental Content

Support Center